Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.95+0.27 (+4.75%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/29/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
79.93M84.82M52.43M64.77M85.69M
Enterprise Value
65.63M70.62M37.88M49.86M71.80M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
5.685.983.594.295.44
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-26.82-122.38-80.07-80.55-92.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3-5.56%
S&P500 52-Week Change 3-13.03%
52 Week High 37.41
52 Week Low 33.66
50-Day Moving Average 35.47
200-Day Moving Average 35.15

Share Statistics

Avg Vol (3 month) 315.99k
Avg Vol (10 day) 316.03k
Shares Outstanding 513.41M
Implied Shares Outstanding 6N/A
Float 89.38M
% Held by Insiders 11.10%
% Held by Institutions 164.26%
Shares Short (Jun 14, 2022) 4290.48k
Short Ratio (Jun 14, 2022) 422.04
Short % of Float (Jun 14, 2022) 42.83%
Short % of Shares Outstanding (Jun 14, 2022) 42.17%
Shares Short (prior month May 12, 2022) 4271.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 22, 2019
Ex-Dividend Date 4Dec 12, 2019
Last Split Factor 21271:1000
Last Split Date 3Sep 05, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-9.84%
Return on Equity (ttm)-12.68%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.89M
Diluted EPS (ttm)-0.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.29M
Total Cash Per Share (mrq)1.07
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)25.91
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)-135k
Levered Free Cash Flow (ttm)1.14M
Advertisement
Advertisement